Significant Ownership of 111 Equity Group
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for 111 Equity Group focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Chaim Herzog - Manager
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow 111 Equity Group with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from 111 Equity Group
Significant Ownership of 111 Equity Group
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MTNB | Matinas Biopharma Holdings, Inc. | Common Stock | 3.6% | $110,183 | -$47,617 | 183,639 | -30% | 111 Equity Group LLC | 13 Feb 2025 |
| VAPE | CEA Industries Inc. | Common Stock | 0% | $0 | 0 | 111 Equity Group LLC | 28 Jul 2025 |
Schedules 13D/G Reported by 111 Equity Group:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.